For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Phentermine & Topiramate | Participants were randomized to receive phentermine and topiramate plus standard post-bariatric care. | 0 | None | 1 | 6 | 6 | 6 | View |
| Placebo | Participants were randomized to receive placebo tablets compounded to look like phentermine and topiramate plus standard post-bariatric care. | 0 | None | 0 | 6 | 6 | 6 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hospital admission | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Restlessness | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Depressed mood | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Difficulty with sleep | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Irritability | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Paresthesias | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Difficulty with concentration/attention | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Nausea/Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Change in Taste | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Eye discomfort | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Flushing | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Memory problems | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Menstruation change | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Mental fogginess | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Shortness of breath | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Word finding difficulties | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Back, side, and/or groin pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| COVID disease | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Fever | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Blurry vision | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Decreased sweating | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Myalgias | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Palpitations | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Esophageal fullness | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Finger fracture | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Inability to cool down | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Swelling in arms, legs, face | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Vaginal pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| Depression Score by CES-D that increased from normal to elevated (>=20) on study | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Suicidality screen (CSSRS) positivity on study | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Low bicarbonate (<20mmol/L) | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Low potassium (<3.5mmol/L) | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Elevated creatinine | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Positive urine pregnancy test | SYSTEMATIC_ASSESSMENT | Pregnancy, puerperium and perinatal conditions | None | View |
| Elevated systolic blood pressure (>=120mmHg) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Elevated diastolic BP (>=80mmHg) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Elevated heart rate (>=100 beats per minute) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Elevated temperature (measured) | SYSTEMATIC_ASSESSMENT | General disorders | None | View |